Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Abruptio placentae].

M Balde1, E M Grischke, W Stolz

  • 1Universitäts-Frauenklinik Heidelberg.

Geburtshilfe Und Frauenheilkunde
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study.

Archives of gynecology and obstetrics·2026
Same author

Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area.

Archives of gynecology and obstetrics·2026
Same author

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2- early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2- trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019).

European journal of cancer (Oxford, England : 1990)·2020
Same author

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study.

Breast (Edinburgh, Scotland)·2019
Same author

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study.

Breast cancer research and treatment·2019

Abruptio placentae, a condition affecting 1 in 182 births, remains unchanged in frequency and clinical pattern. Key associated factors include premature labor, bleeding, and gestosis, impacting perinatal mortality.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine

Context:

  • Retrospective analysis of abruptio placentae cases from 1979-1988.
  • Established frequency of 0.55% (1 in 182 births).

Purpose:

  • To identify significant factors correlated with abruptio placentae.
  • To analyze clinical patterns and outcomes associated with the condition.

Summary:

  • Significant factors include premature labor, vaginal bleeding, and gestosis.
  • High rates of pregnancy complications (abortions, interruptions, premature rupture of membranes, multiple pregnancies) observed.
  • Ultrasound diagnostic utility was limited (7.7%).
  • High incidence of breech presentation (20%) and premature birth (37% ≤ 33 weeks).
  • Coagulation disturbances present in 50% of patients.

Related Experiment Videos

  • Perinatal mortality rate of 12% linked to prematurity and delayed diagnosis.

    • Impact:

    • Highlights the persistent challenges in diagnosing and managing abruptio placentae.
    • Underscores the critical role of timely diagnosis in reducing perinatal mortality.
    • Informs clinical practice regarding risk factors and associated complications.